Who
Martin J. Madden
Director
Company insider
Files Form 4 as: Director, NovoCure; Director, Microbot Medical.
In numbers
- Trades disclosed
- 33
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $22K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 6 Dec 2017
- Last trade
- 3 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | MBOT Microbot Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | MBOT Microbot Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —33,393 at $0.00 | filing |
| 3 Jun 2025filed 4 Jun 2025 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $17K999 at $17.19 | filing |
| 28 Jan 2025filed 30 Jan 2025 | MBOT Microbot Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,229 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —4,053 at $0.00 | filing |
| 2 Nov 2023filed 6 Nov 2023 | MBOT Microbot Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —74,218 at $0.00 | filing |
| 7 Jun 2023filed 9 Jun 2023 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —12,554 at $0.00 | filing |
| 21 Sep 2022filed 23 Sep 2022 | MBOT Microbot Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,637 at $0.00 | filing |
| 8 Jun 2022filed 10 Jun 2022 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —8,700 at $0.00 | filing |
| 29 Sep 2021filed 5 Oct 2021 | MBOT Microbot Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —13,571 at $0.00 | filing |
| 5 Aug 2021filed 6 Aug 2021 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $5,20634 at $153.13 | filing |
| 9 Jun 2021filed 11 Jun 2021 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,499 at $0.00 | filing |
| 9 Jun 2021filed 11 Jun 2021 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —814 at $0.00 | filing |
| 2 Mar 2021filed 4 Mar 2021 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —111 at $0.00 | filing |
News
Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Martin J. Madden; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.